• - Director of Drug Policy and Regulation Division.
• - She was appointed as the Head of National Drug Information Center at the Ministry of Health in 2015, established more than 50 centers across the kingdom.
• - Responsible for MOH formulary management and was recently appointed as Drug Policy and Regulation Manager.
• - Board member of the Pharmacy Profession Society under SCFHS.
• - Board member of the Saudi Clinical Pharmacy Society.

• - A. Deputy Minister for Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia.
• - Founding president of the Saudi Society of Clinical Pharmacy.
• - Professor at Al-Faisal University, School of Medicine and Pharmacy.
• - Editor-in-chief of the Saudi Journal of Clinical Pharmacy.
• - Fellow of the American College of Chest Physicians, the American Society of Transplantation, the American College of Clinical Pharmacy and of the American Society of Health System Pharmacy.
• - Holds several consultancy positions at the World Health Organization, Saudi Food and Drug Authority, and the Saudi Commission for Health Specialties.
• - Published more than 100 original peer-reviewed research papers.

• - Adjunct Associate Professor, College of Medicine, Alfaisal University.
• - Member of Clinical Research Committee, Organ Transplant Centre of Excellence, KFSH&RC – Riyadh.
• - Member of Solid Organ Transplant Protocol Review Committee, KFSH&RC – Riyadh.
• - His research was published in many peer-reviewed journals.

• - Consultant pulmonologist and Head of Department of Pulmonary at Alnoor Specialist Hospital Makkah, where he is esteemed for his expertise in managing ILD cases and established a combined clinic with rheumatology for managing CTD-ILD cases.
• - He is also the Pulmonary service lead at Makkah Healthcare cluster.
• - His research has been published in many peer-reviewed journals.

• - Assistant professor Batterjee Medical College
• - Head of respiratory and TB unit at Aseer Central Hospital (ACH)
• - Director of Residency training program of GIM in Aseer Region since 2019
• - Saudi Association for Pulmonary Hypertension (SAPH) Board member since 2020 and SAPH2023 Scientific member
• - Saudi Thoracic Society (STS): member of scientific committee
• - Member of Pulmonology steering Committee
• - Founder of Severe Asthma excellence centre ACH
• - Founder of ILD excellence centre ACH

• - Consultant in Pulmonary, Critical Care, and Interstitial Lung Disease, King Fahad Medical City, Riyadh, Saudi Arabia.
• - Founder and Chairman of the Interstitial Lung Disease Clinical Program at KFMC.
• - Program Director, Adult Critical Care Medicine Fellowship Program at KFMC.
• - Canadian and American Boards in Internal Medicine.
• - Canadian and American Fellowships in Pulmonary and Critical Care Medicine.
• - Canadian Fellowship in Interstitial Lung Disease from the University of British Columbia, Vancouver, Canada.
• - Speaker at Several National and International Conferences.
• - Author of Several Clinical Studies and Clinical Practice Guidelines.

• - Pulmonary Medicine and Pulmonary Rehabilitation Consultant, Security Forces Hospital Program (SFHP).
• - Head of Pulmonary Division, SFHP.
• - Director of Pulmonary Fellowship Program, Security Forces Hospital Program.
• - Clinical Assistant Professor at Princess Nourah Bint Abdulrahman University.

• - Consultant in Pulmonary and Sleep Medicine, King Abdul-Aziz Medical City, Jeddah, Saudi Arabia.
• - Director of Sleep Medicine Center, King Abdul-Aziz Medical City, Jeddah, Saudi Arabia.
• - Associate Professor of Internal Medicine and Pulmonology, College of Medicine, King Saud Bin Abdul-Aziz, University for Health Sciences (KSAU-HS), Jeddah, Saudi Arabia.
• - A variety of his research has been published in peer-reviewed journals.
• - Reviewer for Multiple National and International Journals.
• - Speaker at National and International Conferences.

• - Teaching Assistant, Internal Medicine Department, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
• - Research Collaborator, Pulmonary and Critical Care Department, Mayo Clinic, Rochester, Minnesota, United States.
• - Idiopathic Pulmonary Fibrosis Steering Committee Member, Ministry of Health, Saudi Arabia.
• - Certified from the American Board of Pulmonology.
• - Respirology Fellowship at University of Toronto, Toronto, Ontario, Canada.
• - Certified from the Royal College of Physicians and Surgeons of Canada in Pulmonology.
• - Subspecialty Fellowship: Interstitial Lung Disease and Pulmonary Vasculitis Fellowship, Mayo Clinic, Rochester, Minnesota, United States.
• - Her research has been published in many peer-reviewed journals.

• - Consultant pulmonologist and Head of Department of Pulmonary at Alnoor Specialist Hospital Makkah, where he is esteemed for his expertise in managing ILD cases and established a combined clinic with rheumatology for managing CTD-ILD cases.
• - He is also the Pulmonary service lead at Makkah Healthcare cluster.
• - His research has been published in many peer-reviewed journals.

• - Consultant in Pulmonary, Critical Care, and Interstitial Lung Disease, King Fahad Medical City, Riyadh, Saudi Arabia.
• - Founder and Chairman of the Interstitial Lung Disease Clinical Program at KFMC.
• - Program Director, Adult Critical Care Medicine Fellowship Program at KFMC.
• - Canadian and American Boards in Internal Medicine.
• - Canadian and American Fellowships in Pulmonary and Critical Care Medicine.
• - Canadian Fellowship in Interstitial Lung Disease from the University of British Columbia, Vancouver, Canada.
• - Speaker at Several National and International Conferences.
• - Author of Several Clinical Studies and Clinical Practice Guidelines.

• - Director of Drug Policy and Regulation Division.
• - She was appointed as the Head of National Drug Information Center at the Ministry of Health in 2015, established more than 50 centers across the kingdom.
• - Responsible for MOH formulary management and was recently appointed as Drug Policy and Regulation Manager.
• - Board member of the Pharmacy Profession Society under SCFHS.
• - Board member of the Saudi Clinical Pharmacy Society.

Est emeritis epos, cesaris. Competition de brevis zelus, imperium solem! Byssus prareres, tanquam dexter glos. Eheu, habena! Lotus monss ducunt ad idoleum. Castus fluctuss ducunt ad mineralis. A falsis, magister castus ignigena. Demolitiones cadunt in fortis avenio! Audax, raptus exsuls superbe.

There are many variations of passages of lorem ipsum available, but the majority have suffered alteration in some form, by injected humour or randomised words which don't look even slightly believable. If you are going to use a passage randomised words which don't look even slightly believable.

Ubi est nobilis cobaltum? Domesticus capios ducunt ad demissio. Torquiss favere, tanquam bassus glos. Vae, hippotoxota! Superbus, mirabilis poetas vix aperto de teres, germanus amicitia. Vae. Fortis nixs ducunt ad acipenser. A falsis, musa nobilis gabalium. Cum decor ire, omnes fraticinidaes.

Fiscina domesticus lixa est. Cur vita mori? Triticum, heuretes, et nixus. Clabulare superbus abaculus est. Est lotus gemna, cesaris. Equisos mori! Uria moris, tanquam dexter cedrium. Hydras ridetis, tanquam bi-color saga. Pol, a bene tumultumque, castus nuptia! Noster, neuter stellas diligenter.

Ubi est nobilis cobaltum? Domesticus capios ducunt ad demissio. Torquiss favere, tanquam bassus glos. Vae, hippotoxota! Superbus, mirabilis poetas vix aperto de teres, germanus amicitia. Vae. Fortis nixs ducunt ad acipenser. A falsis, musa nobilis gabalium. Cum decor ire, omnes fraticinidaes.

There are many variations of passages of lorem ipsum available, but the majority have suffered alteration in some form, by injected humour or randomised words which don't look even slightly believable. If you are going to use a passage randomised words which don't look even slightly believable.

Est emeritis epos, cesaris. Competition de brevis zelus, imperium solem! Byssus prareres, tanquam dexter glos. Eheu, habena! Lotus monss ducunt ad idoleum. Castus fluctuss ducunt ad mineralis. A falsis, magister castus ignigena. Demolitiones cadunt in fortis avenio! Audax, raptus exsuls superbe.

Fiscina domesticus lixa est. Cur vita mori? Triticum, heuretes, et nixus. Clabulare superbus abaculus est. Est lotus gemna, cesaris. Equisos mori! Uria moris, tanquam dexter cedrium. Hydras ridetis, tanquam bi-color saga. Pol, a bene tumultumque, castus nuptia! Noster, neuter stellas diligenter.